Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Lung Cancer

Free Subscription 20.04.2026 1 Am J Clin Oncol 1 Am J Epidemiol 6 Ann Surg Oncol 1 Ann Thorac Surg 8 BMC Cancer 1 Cancer Lett 3 Cancer Res 3 Chest 2 Clin Cancer Res 1 Clin Lung Cancer 2 Eur J Cancer 2 Eur Respir J 1 J Clin Invest 1 J Clin Oncol 2 J Thorac Oncol 12 Lung Cancer 1 N Engl J Med 1 Oncogene 2 Oncologist 1 PLoS One 1 Proc Natl Acad Sci U S A 1 Science 3 Thorax

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Clin Oncol

1. BOMMIREDDY A, Angelov L, Suh JH, Murphy ES, et al
   Local Control Outcomes of Patients With Brain Metastases From Small Cell Lung Cancer Treated With Stereotactic Radiosurgery.
   Am J Clin Oncol. 2026 Apr 6. doi: 10.1097/COC.0000000000001325.
   PubMed         Abstract available
   
   

   
   Am J Epidemiol

2. RUDOLPH JE, Zhou Y, Palatino M, Yenokyan K, et al
   Sampling for computational efficiency when conducting analyses in big data.
   Am J Epidemiol. 2025 Dec 5:kwaf268. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

3. TANG D, Wu J, Li X, Deng C, et al
   ASO Visual Abstract: Thoracoscopic Incomplete Anatomical Segmentectomy for Ground-Glass-Dominant Lung Cancer: Associations with Lower Postoperative Cough Burden and Faster Symptom Recovery.
   Ann Surg Oncol. 2026 Apr 15. doi: 10.1245/s10434-026-19548.
   PubMed        
   
   
4. FERRARI M, Valsecchi C, Leuzzi G, Rolli L, et al
   Long-Term Results of Multiple Pulmonary Metastasectomies.
   Ann Surg Oncol. 2026;33:4313-4323.
   PubMed         Abstract available
   
   
5. MACHADO GF, Grillo ITC, D'ambrosio PD, Romao VT, et al
   Real-World Long-Term Outcomes of First-Line Pembrolizumab in Advanced PD-L1 >/= 50% NSCLC: A Systematic Review and Meta-analysis.
   Ann Surg Oncol. 2026;33:4324-4335.
   PubMed         Abstract available
   
   
6. OU DX, Chen LW, Chen KY, Wang HJ, et al
   CT-based Prediction of Visceral Pleural Invasion in Lung Adenocarcinoma
   Ann Surg Oncol. 2026;33:4256-4266.
   PubMed         Abstract available
   
   
7. ZHANG L, Ye W, Zhou Y, Yang D, et al
   Computed Tomography-Pathology Deep Learning Model for the Precise Prediction of Recurrence in Pathological Stage IA Lung Adenocarcinoma.
   Ann Surg Oncol. 2026;33:4184-4193.
   PubMed         Abstract available
   
   
8. TANG D, Wu J, Li X, Deng C, et al
   Thoracoscopic Incomplete Anatomical Segmentectomy for Ground-Glass-Dominant Lung Cancer: Associations with Lower Postoperative Cough Burden and Faster Symptom Recovery.
   Ann Surg Oncol. 2026 Apr 15. doi: 10.1245/s10434-026-19216.
   PubMed         Abstract available
   
   

   
   Ann Thorac Surg

9. YOON DW, Shin DW, Jung J, Joh HS, et al
   Short- and Long-Term Risks of Atrial Fibrillation in Surgically Treated Lung Cancer Patients: A Korean Nationwide Study.
   Ann Thorac Surg. 2026 Apr 8:S0003-4975(26)00320.
   PubMed         Abstract available
   
   

   
   BMC Cancer

10. PHAM VH, Duong DC, Nguyen VB, Do HN, et al
    Real-world trends in diagnosis, treatment, and survival of non-small cell lung cancer in Vietnam.
    BMC Cancer. 2026 Apr 14. doi: 10.1186/s12885-026-15982.
    PubMed         Abstract available
    
    
11. ERDIZCI P, Ersoz Kose E, Akyil M, Atinkaya Baytemir C, et al
    Comparison of prognosis between patients undergoing surgical resection and stereotactic ablative radiotherapy for early-stage lung cancer.
    BMC Cancer. 2026 Apr 14. doi: 10.1186/s12885-026-16008.
    PubMed        
    
    
12. WU Y, Cheng S, Huang Y, Kuang W, et al
    Multimodal prehabilitation management within the framework of enhanced recovery after surgery in patients undergoing lung cancer surgery: a scoping review.
    BMC Cancer. 2026 Apr 13. doi: 10.1186/s12885-026-15788.
    PubMed        
    
    
13. MAO Y, Wang A, Qin B, Zhai J, et al
    Efficacy and safety of low-intensity chemotherapy combined with immunotherapy in elderly patients with locally advanced and metastatic non-small cell lung cancer: a retrospective analysis.
    BMC Cancer. 2026 Apr 11. doi: 10.1186/s12885-026-15943.
    PubMed        
    
    
14. CAO G, Di X, Liu X, Wang Z, et al
    Dose-effect relationship of D90 in iodine-125 seed implantation for advanced lung cancer: gradient-based efficacy and survival outcome.
    BMC Cancer. 2026 Apr 10. doi: 10.1186/s12885-026-15798.
    PubMed        
    
    
15. TENG H, Qin N, Liu K, Gong C, et al
    Efficacy and safety of albumin-bound paclitaxel combined with anlotinib and immunotherapy in advanced non-small cell lung cancer with liver metastases: a retrospective study.
    BMC Cancer. 2026 Apr 11. doi: 10.1186/s12885-026-15996.
    PubMed        
    
    
16. ZHAO L, Li J, Liu Y, Chen L, et al
    Global trends and projections of lung cancer attributable to residential radon exposure, 1990-2050.
    BMC Cancer. 2026 Apr 16. doi: 10.1186/s12885-026-15990.
    PubMed        
    
    
17. ZHOU K, Bai Y, Deng L, Xie T, et al
    A multimodal immuno-radiologic model integrating circulating sPD-L1/CXCL9 and spectral CT iodine metrics to stratify postoperative relapse risk in non-small cell lung cancer.
    BMC Cancer. 2026 Apr 16. doi: 10.1186/s12885-026-16002.
    PubMed        
    
    

    
    Cancer Lett

18. YANG L, Yang H, Zhao M, Wen Y, et al
    IGHG1(+) malignant epithelial Cell-myCAF crosstalk via MIF-CD74/APP-CD74 drives early brain metastasis in NSCLC: Delineated via primary tumor-brain metastasis single-cell and spatial transcriptomics.
    Cancer Lett. 2026;647:218451.
    PubMed         Abstract available
    
    

    
    Cancer Res

19. CHEN S, Chang C, Liu X, Wang R, et al
    ACSL5 Mediates Adaptation to the Palmitic Acid-Enriched Pulmonary Microenvironment to Enhance Metastatic Breast Cancer Cell Survival and Lung Metastasis.
    Cancer Res. 2026 Jan 22. doi: 10.1158/0008-5472.CAN-25-0866.
    PubMed         Abstract available
    
    
20. SABOL HM, Bravo-Cordero JJ, Borriello L
    Acting on Dormancy: The Interplay Between the Actin Cytoskeleton and Tumor Cell Dormancy.
    Cancer Res. 2026;86:1820-1822.
    PubMed         Abstract available
    
    
21. ASSELIN-LABAT ML, Kallies A
    Epigenetic imprinting bridges infection and lung cancer.
    Cancer Res. 2026 Apr 13. doi: 10.1158/0008-5472.CAN-26-1511.
    PubMed         Abstract available
    
    

    
    Chest

22. BAPTISTE JV
    Process Improvement for Clinical Follow-Up of Incidental Lung Nodules: A Practical Perspective.
    Chest. 2026;169:1135-1141.
    PubMed         Abstract available
    
    
23. BOSTER JM, Goertzen M, Sarkiss M, Armas Villalba AJ, et al
    Superiority of Lateral Decubitus Strategy in Preventing Atelectasis From Obscuring Targets During Robotic Bronchoscopy: Lateral Decubitus Strategy vs Ventilatory Strategy to Prevent Atelectasis Trial.
    Chest. 2026;169:1124-1134.
    PubMed         Abstract available
    
    
24. MARTINEZ MANZANO JM, Gottumukkala RV, Divo MJ, Ramaswamy A, et al
    A 71-Year-Old Woman With Dyspnea and Hypoxemia After Liver Metastases Cryoablation.
    Chest. 2026;169:e129-e134.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

25. GRAY JE, Neal JW, Patel JD, Liu SV, et al
    First-Line Sacituzumab Govitecan Plus Pembrolizumab and Carboplatin in Metastatic Non-Small Cell Lung Cancer: Nonsquamous and Squamous Cohorts of the EVOKE-02 Study.
    Clin Cancer Res. 2026 Apr 10. doi: 10.1158/1078-0432.CCR-25-4485.
    PubMed         Abstract available
    
    
26. THURSBY SJ, Jin Z, Blum J, Gurau A, et al
    Epigenetic Instability-Based Metrics in Cell-Free DNA for Early Cancer Detection.
    Clin Cancer Res. 2026;32:1528-1539.
    PubMed         Abstract available
    
    

    
    Clin Lung Cancer

27. WANG Y, Donovan EK, Levine MN, Whelan TJ, et al
    Stereotactic Versus Conventional Radiotherapy in Medically Inoperable Stage I Non-Small Cell Lung Cancer: A Bayesian Reanalysis of the LUSTRE Randomized Trial.
    Clin Lung Cancer. 2026 Mar 26:S1525-7304(26)00042.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

28. AL-TOMA D, Kemna R, Ali M, Zwart K, et al
    Tumor burden in metastatic colorectal cancer quantified using deep learning models: Prognostic value and maintenance treatment benefit in the CAIRO3 trial.
    Eur J Cancer. 2026;238:116668.
    PubMed         Abstract available
    
    
29. JUDICKIENE J, Metzenmacher M, Zaun G, Wiesweg M, et al
    Pretherapeutic prognostic factors for survival under chemoimmunotherapy/immunotherapy of advanced NSCLC patients.
    Eur J Cancer. 2026;238:116600.
    PubMed         Abstract available
    
    

    
    Eur Respir J

30. HEDMAN K, Kristenson K
    Comment on: European Respiratory Society and European Society of Thoracic Surgeons clinical practice guideline on fitness for curative intent treatment of lung cancer.
    Eur Respir J. 2026;67:2502480.
    PubMed         Abstract available
    
    
31. BRUNELLI A, Hardavella G, Huber RM, Berghmans T, et al
    Reply regarding the European Respiratory Society and European Society of Thoracic Surgeons clinical practice guideline on fitness for curative intent treatment of lung cancer.
    Eur Respir J. 2026;67:2502601.
    PubMed        
    
    

    
    J Clin Invest

32. ZHAO Y, Zhou Y, Pan L, Tian GG, et al
    Therapy-induced cholesterol biosynthesis drives lung cancer dormancy and drug resistance.
    J Clin Invest. 2026;136:e191735.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

33. WALTER TP, Mazieres J, Otto J, Lena H, et al
    Nivolumab +/- Ipilimumab in Patients With Pretreated Advanced Neuroendocrine Carcinoma: The GCO-001 NIPINEC Randomized Phase II Trial.
    J Clin Oncol. 2026;44:1120-1129.
    PubMed         Abstract available
    
    

    
    J Thorac Oncol

34. MONACA F, Gomez-Randulfe I, Torres-Jimenez J, Agarwal M, et al
    Antibody-Drug Conjugates in Small-Cell Lung Cancer: DLL3, B7-H3, TROP2 and Beyond.
    J Thorac Oncol. 2026 Apr 13:103726. doi: 10.1016/j.jtho.2026.103726.
    PubMed         Abstract available
    
    
35. ARDESHIR-LARINANI F, Ashrafian L, Chiappetta M, Mansilla D, et al
    Challenges and Controversies in the Diagnosis and Management of Thymic Epithelial Tumors from the Thymic Tumor Subcommittee of the International Association for the Study of Lung Cancer Rare Tumors Committee.
    J Thorac Oncol. 2026 Apr 10:103611. doi: 10.1016/j.jtho.2026.103611.
    PubMed         Abstract available
    
    

    
    Lung Cancer

36. BARLESI F, Ahn JS, Solomon BJ, Nishio M, et al
    Disease characteristics and treatment outcomes in patients with resected early-stage ALK-positive non-small cell lung cancer from the randomized ALINA trial.
    Lung Cancer. 2026;216:109385.
    PubMed         Abstract available
    
    
37. DONG X, Jian H, Huang M, Yuan S, et al
    Osimertinib after definitive chemoradiotherapy in patients with unresectable stage III EGFR-mutated NSCLC: LAURA China cohort.
    Lung Cancer. 2026;215:109343.
    PubMed         Abstract available
    
    
38. LI Y, Zhang FX, Zhang WL, Shen MJ, et al
    (18)F-FDG PET/CT and receptor-positive circulating tumor cells-based machine learning model for predicting poorly differentiated lung adenocarcinoma.
    Lung Cancer. 2026;215:109353.
    PubMed         Abstract available
    
    
39. ZHANG Y, Chen L, Dai W, Zhou Y, et al
    Hypermethylation of SHOX2 and RASSF1A in intraoperative pleural lavage fluid as a molecular signature of aggressive tumor biology and high histologic grade in stage I lung adenocarcinoma.
    Lung Cancer. 2026;215:109357.
    PubMed         Abstract available
    
    
40. ORTMEYER WELCH K, McGovern KA, Chen L, Welch JC, et al
    SGLT2 inhibitor use reduces progression and surgical intervention of persistent pulmonary nodules.
    Lung Cancer. 2026;215:109356.
    PubMed         Abstract available
    
    
41. DAVILA-DUPONT D, Arroyo-Hernandez M, Turcott JG, Palomares-Palomares CB, et al
    Respiratory sarcopenia and prehabilitation in thoracic oncology: Diagnostic approaches and clinical implications.
    Lung Cancer. 2026;215:108949.
    PubMed         Abstract available
    
    
42. LAMBERTI G, Andrini E, Zappi A, Di Odoardo A, et al
    Phase III meta-analysis of first-line chemo-immunotherapy in ES-SCLC: Survival benefit without detectable class-level differences.
    Lung Cancer. 2026;215:109376.
    PubMed         Abstract available
    
    
43. NAKAI T, Matsumoto Y, Yamada K, Watanabe T, et al
    Novel thin convex-probe endobronchial ultrasound bronchoscope-guided cryobiopsy for a peripheral pulmonary lesion.
    Lung Cancer. 2026;215:109375.
    PubMed         Abstract available
    
    
44. VISBY L, Kehlet H, Secher EL, Moller-Sorensen H, et al
    Outcomes of Video-Assisted Thoracoscopic Lobectomy in Octogenarians Following Enhanced Recovery After Surgery Protocols.
    Lung Cancer. 2026;215:109384.
    PubMed         Abstract available
    
    
45. WANG K, Ding Y, Wang Z, Zhao Y, et al
    Risk stratification in stage I invasive non-mucinous lung adenocarcinoma based on high-risk histopathologic features.
    Lung Cancer. 2026;215:109388.
    PubMed         Abstract available
    
    
46. 
    Expression of concern for "'Recoverin as a paraneoplastic antigen in lung cancer: the occurrence of anti-recoverin autoantibodies in sera and recoverin in tumors' by Pavel P Philippov". [Lung Cancer 44(2) (2004) 193-198, https://doi.org/10.1016/j.lung
    Lung Cancer. 2026;215:109332.
    PubMed        
    
    
47. ZHAI W, Liang D, Yu X, Dai S, et al
    Surgery after neoadjuvant immunochemotherapy versus immuno-chemoradiotherapy in patients with cN3 non-small cell lung cancer: A cohort study in two academic centers.
    Lung Cancer. 2026;216:109409.
    PubMed         Abstract available
    
    

    
    N Engl J Med

48. HEYMACH JV, Yamamoto N, Girard N, Ruiter G, et al
    First-Line Zongertinib in Advanced HER2-Mutant Non-Small-Cell Lung Cancer.
    N Engl J Med. 2026 Apr 15. doi: 10.1056/NEJMoa2516969.
    PubMed         Abstract available
    
    

    
    Oncogene

49. HEIL BN, Baral G, Pfeffer CM, Bahler MB, et al
    Suppression of PP2A-B56alpha drives EMT in EGFR mutant non-small cell lung cancer.
    Oncogene. 2026 Apr 11. doi: 10.1038/s41388-026-03772.
    PubMed         Abstract available
    
    

    
    Oncologist

50. BAUTISTA-GONZALEZ E DR, Aguerrebere M, Peasey A, Pikhart H Prof, et al
    Health system strengthening recommendations for Lung Cancer Care: Lessons from the COVID-19 Pandemic.
    Oncologist. 2026 Apr 16:oyag144. doi: 10.1093.
    PubMed         Abstract available
    
    
51. IANCU A, Gwin W, Vinayak S, Linden HM, et al
    Incidental discovery of second primary lung tumors in breast cancer patients: an institutional case series.
    Oncologist. 2026;31:oyag083.
    PubMed         Abstract available
    
    

    
    PLoS One

52. MI F, Xu Y, Mi S
    LungNet: Leveraging state-space models with SE-enhanced skip connections for precise CT-based lung lesion segmentation.
    PLoS One. 2026;21:e0346561.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

53. FARIAS A, Bridgeman VL, Rodrigues FS, Puttur F, et al
    Type I interferons induced upon respiratory viral infection impair lung metastatic initiation.
    Proc Natl Acad Sci U S A. 2026;123:e2412919123.
    PubMed         Abstract available
    
    

    
    Science

54. ZHANG Y, Ouadah Y, Liu Y, Kumar ME, et al
    Stem cell control in the lung by an autocrine injury-activated Igf complex.
    Science. 2026;392:eadt1310.
    PubMed         Abstract available
    
    

    
    Thorax

55. GHERZI L, Daffre E, Prieto M, Thomas PA, et al
    Clustering by patients-related characteristics identifies specific phenotypes with different prognosis after resection of non-small cell lung cancer: a French nationwide study from the Epithor database.
    Thorax. 2026 Apr 17:thorax-2025-224424. doi: 10.1136/thorax-2025-224424.
    PubMed         Abstract available
    
    
56. SUAZO-ZEPEDA E, Talen GG, van der Werf S, Hiltermann JTJN, et al
    Sex-based differences in effectiveness of immune checkpoint inhibitors in the treatment of advanced non-small-cell lung cancer: systematic review and meta-analysis.
    Thorax. 2026 Apr 17:thorax-2025-223372. doi: 10.1136/thorax-2025-223372.
    PubMed         Abstract available
    
    
57. FILAKOVSZKY A, Brat K, Tschoellitsch T, Bartos S, et al
    Cardiopulmonary exercise testing before lung resection surgery: still indicated? Evaluating predictive utility using machine learning.
    Thorax. 2026;81:474-482.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum